Literature DB >> 21628403

Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.

Louise van der Weyden1, George Giotopoulos, Alistair G Rust, Louise S Matheson, Frederik W van Delft, Jun Kong, Anne E Corcoran, Mel F Greaves, Charles G Mullighan, Brian J Huntly, David J Adams.   

Abstract

The t(12;21) translocation that generates the ETV6-RUNX1 (TEL-AML1) fusion gene, is the most common chromosomal rearrangement in childhood cancer and is exclusively associated with B-cell precursor acute lymphoblastic leukemia (BCP-ALL). The translocation arises in utero and is necessary but insufficient for the development of leukemia. Single-nucleotide polymorphism array analysis of ETV6-RUNX1 patient samples has identified multiple additional genetic alterations; however, the role of these lesions in leukemogenesis remains undetermined. Moreover, murine models of ETV6-RUNX1 ALL that faithfully recapitulate the human disease are lacking. To identify novel genes that cooperate with ETV6-RUNX1 in leukemogenesis, we generated a mouse model that uses the endogenous Etv6 locus to coexpress the Etv6-RUNX1 fusion and Sleeping Beauty transposase. An insertional mutagenesis screen was performed by intercrossing these mice with those carrying a Sleeping Beauty transposon array. In contrast to previous models, a substantial proportion (20%) of the offspring developed BCP-ALL. Isolation of the transposon insertion sites identified genes known to be associated with BCP-ALL, including Ebf1 and Epor, in addition to other novel candidates. This is the first mouse model of ETV6-RUNX1 to develop BCP-ALL and provides important insight into the cooperating genetic alterations in ETV6-RUNX1 leukemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628403      PMCID: PMC3622520          DOI: 10.1182/blood-2011-02-338848

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL.

Authors:  L C Wang; F Kuo; Y Fujiwara; D G Gilliland; T R Golub; S H Orkin
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.

Authors:  Alexandra Schebesta; Shane McManus; Giorgia Salvagiotto; Alessio Delogu; Georg A Busslinger; Meinrad Busslinger
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

3.  Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.

Authors:  Meike Fischer; Maike Schwieger; Stefan Horn; Birte Niebuhr; Anthony Ford; Susanne Roscher; Ulla Bergholz; Mel Greaves; Jürgen Löhler; Carol Stocking
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

4.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Authors:  Lara S Collier; Corey M Carlson; Shruthi Ravimohan; Adam J Dupuy; David A Largaespada
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  Chemokine receptor expression in B-cell lymphoproliferative disorders.

Authors:  Sue Wong; David Fulcher
Journal:  Leuk Lymphoma       Date:  2004-12

6.  Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.

Authors:  Albert G Tsai; Haihui Lu; Sathees C Raghavan; Markus Muschen; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

7.  Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.

Authors:  Bernard M Fine; Martin Stanulla; Martin Schrappe; Minh Ho; Susanne Viehmann; Jochen Harbott; Linda M Boxer
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

8.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

9.  Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Authors:  Takashi Akasaka; Theodore Balasas; Lisa J Russell; Kei-ji Sugimoto; Aneela Majid; Renata Walewska; E Loraine Karran; David G Brown; Kelvin Cain; Lana Harder; Stefan Gesk; Jose Ignacio Martin-Subero; Mark G Atherton; Monika Brüggemann; María José Calasanz; Teresa Davies; Oskar A Haas; Anne Hagemeijer; Helena Kempski; Michel Lessard; Debra M Lillington; Sarah Moore; Florence Nguyen-Khac; Isabelle Radford-Weiss; Claudia Schoch; Stéphanie Struski; Polly Talley; Melanie J Welham; Helen Worley; Jon C Strefford; Christine J Harrison; Reiner Siebert; Martin J S Dyer
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

10.  Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens.

Authors:  Jeroen de Ridder; Anthony Uren; Jaap Kool; Marcel Reinders; Lodewyk Wessels
Journal:  PLoS Comput Biol       Date:  2006-10-24       Impact factor: 4.475

View more
  37 in total

1.  Immunophenotyping of Murine Precursor B-Cell Leukemia/Lymphoma: A Comparison of Immunohistochemistry and Flow Cytometry.

Authors:  Laura J Janke; Charles G Mullighan; Jinjun Dang; Jerold E Rehg
Journal:  Vet Pathol       Date:  2019-06-06       Impact factor: 2.221

2.  Dangerous fusions: a path to cancer for arrested lymphoid progenitors.

Authors:  Ameera Alsadeq; Hassan Jumaa
Journal:  EMBO J       Date:  2017-03-08       Impact factor: 11.598

Review 3.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

4.  Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.

Authors:  Pablo Iglesias; Ann-Christin Puller; Marcos Seoane; Michael Spohn; Sabine Raasch; Marianne Klokow; Jürgen Müller; Lia Burkhardt; Daniela Indenbirken; Martin A Horstmann
Journal:  Blood Adv       Date:  2021-03-09

5.  ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.

Authors:  Hans-Peter Kantner; Wolfgang Warsch; Alessio Delogu; Eva Bauer; Harald Esterbauer; Emilio Casanova; Veronika Sexl; Dagmar Stoiber
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

6.  BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Authors:  Karen A Dun; Rob Vanhaeften; Tracey J Batt; Louise A Riley; Giuseppe Diano; Jan Williamson
Journal:  Blood Adv       Date:  2016-11-30

7.  Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.

Authors:  Atsushi Watanabe; Kunio Miyake; Jessica Nordlund; Ann-Christine Syvänen; Louise van der Weyden; Hiroaki Honda; Norimasa Yamasaki; Akiko Nagamachi; Toshiya Inaba; Tomokatsu Ikawa; Kevin Y Urayama; Nobutaka Kiyokawa; Akira Ohara; Shunsuke Kimura; Yasuo Kubota; Junko Takita; Hiroaki Goto; Kimiyoshi Sakaguchi; Masayoshi Minegishi; Shotaro Iwamoto; Tamao Shinohara; Keiko Kagami; Masako Abe; Koshi Akahane; Kumiko Goi; Kanji Sugita; Takeshi Inukai
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

8.  Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.

Authors:  D Alpar; D Wren; L Ermini; M B Mansur; F W van Delft; C M Bateman; I Titley; L Kearney; T Szczepanski; D Gonzalez; A M Ford; N E Potter; M Greaves
Journal:  Leukemia       Date:  2014-11-12       Impact factor: 11.528

Review 9.  Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.

Authors:  Barbara R Tschida; David A Largaespada; Vincent W Keng
Journal:  Semin Cell Dev Biol       Date:  2014-01-24       Impact factor: 7.727

10.  Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer.

Authors:  Laura M Rogers; Alicia K Olivier; David K Meyerholz; Adam J Dupuy
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.